Beate Kamlage
Berlin, BE, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Validation of two plasma multimetabolite signatures for patients at risk of or with suspected pancreatic ductal adenocarcinoma (METAPAC): a prospective, multicentre, investigator-masked, enrichment design, phase 4 diagnostic study.
Journal: The lancet. Gastroenterology & hepatology
Published: November 22, 2024
Independent Validation and Assay Standardization of Improved Metabolic Biomarker Signature to Differentiate Pancreatic Ductal Adenocarcinoma From Chronic Pancreatitis.
Journal: Gastroenterology
Published: February 01, 2022
Plasma Metabolome Profiling Identifies Metabolic Subtypes of Pancreatic Ductal Adenocarcinoma.
Journal: Cells
Published: June 08, 2021
New Onset of DiabetEs in aSsociation with pancreatic ductal adenocarcinoma (NODES Trial): protocol of a prospective, multicentre observational trial.
Journal: BMJ open
Published: January 14, 2021
Stability of the Human Plasma Proteome to Pre-analytical Variability as Assessed by an Aptamer-Based Approach.
Journal: Journal of proteome research
Published: August 24, 2019
An Integrated Analysis of Metabolites, Peptides, and Inflammation Biomarkers for Assessment of Preanalytical Variability of Human Plasma.
Journal: Journal of proteome research
Published: May 11, 2019
Effects of Long-Term Storage at -80 °C on the Human Plasma Metabolome.
Journal: Metabolites
Published: March 20, 2019
Branched-chain amino acid catabolism rather than amino acids plasma concentrations is associated with diet-induced changes in insulin resistance in overweight to obese individuals.
Journal: Nutrition, metabolism, and cardiovascular diseases : NMCD
Published: February 27, 2017
Integration of tissue metabolomics, transcriptomics and immunohistochemistry reveals ERG- and gleason score-specific metabolomic alterations in prostate cancer.
Journal: Oncotarget
Published: July 14, 2015
Last Updated: 09/26/2026